Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell
• Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022.
INSPIRE Announces The Appointment Of Sayi Puligandla As Chief Operating Officer
INSPIRE, a global event solutions company owned by Ashford Inc. (NYSE:AINC), is pleased to announce the appointment of Sayi Puligandla as Chief Operating Officer.
DALLAS, Feb. 7,
Ashford Q3 EPS $1.48 Beats $1.35 Estimate, Sales $164.61M Beat $148.20M Estimate
Ashford (AMEX:AINC) reported quarterly earnings of $1.48 per share which beat the analyst consensus estimate of $1.35 by 9.63 percent. This is a 33.33 percent increase over earnings of $1.11 per share from the same
BlackRock (BLK) Tops Q3 Earnings Estimates
BlackRock (NYSE: BLK) came out with quarterly earnings of $9.55 per share, beating the Zacks Consensus Estimate of $7.70 per share. This compares to earnings of $10.95 per share a year ago. These figures are adjusted for non-recurring items.
Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday
U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday’s Mid-Day Session
Gainers
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
Recap: Ashford Q2 Earnings
Ashford (AMEX:AINC) reported its Q2 earnings results on Wednesday, August 3, 2022 at 04:30 PM.
Here's what investors need to know about the announcement.
Earnings
Ashford beat estimated earnings by 82.64%, reporting an EPS of $2.21 versus an estimate of $1.21.
Earnings Outlook For Ashford Inc. Common Stock
Ashford Inc. Common Stock (AMEX:AINC) is set to give its latest quarterly earnings report on Wednesday, 2022-08-03. Here's what investors need to know before the announcement.
Analysts estimate that Ashford Inc. Common Stock will report an earnings per share (EPS) of $1.21.
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.